Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of pyrosequencing to detect clinically relevant polymorphisms in dihydropyrimidine dehydrogenase.

× No keyword cloud information.

7 in total

1. Genotyping of single nucleotide substitutions.

Authors: Cyril D S Mamotte
Journal: Clin Biochem Rev Date: 2006-02

Review 2. Can knowledge of germline markers of toxicity optimize dosing and efficacy of cancer therapy?

Authors: Daniel Crona; Federico Innocenti
Journal: Biomark Med Date: 2012-06 Impact factor: 2.851

3. The Role of Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Polymorphisms in Fluoropyrimidine-Based Cancer Chemotherapy in an Iranian Population.

Authors: Mohammad Hadi Abbasian; Nafiseh Ansarinejad; Bahareh Abbasi; Masoud Iravani; Tayeb Ramim; Fahime Hamedi; Ali M Ardekani
Journal: Avicenna J Med Biotechnol Date: 2020 Jul-Sep

4. Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.

Authors: Michelle A Rudek; Roisin M Connolly; Janelle M Hoskins; Elizabeth Garrett-Mayer; Stacie C Jeter; Deborah K Armstrong; John H Fetting; Vered Stearns; Laurie A Wright; Ming Zhao; Stanley P Watkins; Howard L McLeod; Nancy E Davidson; Antonio C Wolff
Journal: Breast Cancer Res Treat Date: 2013-04-16 Impact factor: 4.872

5. Polymorphism of TS 3'-UTR predicts survival of Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.

Authors: J Gao; Q He; D Hua; Y Mao; Y Li; L Shen
Journal: Clin Transl Oncol Date: 2012-12-21 Impact factor: 3.405

6. Dihydro pyrimidine dehydrogenase deficiency in patients treated with capecitabine based regimens: a tertiary care centre experience.

Authors: Arvind Sahu; Anant Ramaswamy; Vikas Ostwal
Journal: J Gastrointest Oncol Date: 2016-06

7. DPYD*5 gene mutation contributes to the reduced DPYD enzyme activity and chemotherapeutic toxicity of 5-FU: results from genotyping study on 75 gastric carcinoma and colon carcinoma patients.

Authors: Hong Zhang; You-ming Li; Hao Zhang; Xi Jin
Journal: Med Oncol Date: 2007 Impact factor: 3.064

7 in total